Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-133432

Chief Financial Officer acquired 462 shares (grant or award)

  • Chief Financial Officer gave up 182 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2024-12-02 Shares withheld for taxes −182 $57.68 $10,498 12,336 D
Mokari Atabak Chief Financial Officer 2024-12-02 Grant or award +231 $59.21 $13,678 12,567 D
Mokari Atabak Chief Financial Officer 2024-12-02 Grant or award +231 12,798 D
Loading xslF345X05/ownership.xml…